Dimerix Limited

CHIA:DXB Stock Report

Market Cap: AU$207.8m

Dimerix Management

Management criteria checks 2/4

Dimerix's CEO is Nina Webster, appointed in Aug 2018, has a tenure of 6.42 years. total yearly compensation is A$759.06K, comprised of 49.1% salary and 50.9% bonuses, including company stock and options. directly owns 0.073% of the company’s shares, worth A$152.44K. The average tenure of the management team and the board of directors is 3.6 years and 7.3 years respectively.

Key information

Nina Webster

Chief executive officer

AU$759.1k

Total compensation

CEO salary percentage49.1%
CEO tenure6.4yrs
CEO ownership0.07%
Management average tenure3.6yrs
Board average tenure7.3yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Nina Webster's remuneration changed compared to Dimerix's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024AU$759kAU$373k

-AU$17m

Mar 31 2024n/an/a

-AU$14m

Dec 31 2023n/an/a

-AU$11m

Sep 30 2023n/an/a

-AU$12m

Jun 30 2023AU$387kAU$350k

-AU$14m

Mar 31 2023n/an/a

-AU$14m

Dec 31 2022n/an/a

-AU$14m

Sep 30 2022n/an/a

-AU$12m

Jun 30 2022AU$517kAU$341k

-AU$10m

Mar 31 2022n/an/a

-AU$10m

Dec 31 2021n/an/a

-AU$9m

Sep 30 2021n/an/a

-AU$7m

Jun 30 2021AU$408kAU$334k

-AU$6m

Mar 31 2021n/an/a

-AU$6m

Dec 31 2020n/an/a

-AU$6m

Sep 30 2020n/an/a

-AU$5m

Jun 30 2020AU$539kAU$304k

-AU$4m

Mar 31 2020n/an/a

-AU$4m

Dec 31 2019n/an/a

-AU$4m

Sep 30 2019n/an/a

-AU$4m

Jun 30 2019AU$486kAU$221k

-AU$3m

Compensation vs Market: Nina's total compensation ($USD471.82K) is above average for companies of similar size in the Australian market ($USD283.29K).

Compensation vs Earnings: Nina's compensation has increased whilst the company is unprofitable.

CEO

Nina Webster

6.4yrs

Tenure

AU$759,063

Compensation

Dr. Nina Webster, Ph D., BSc (Hons), M IP Law, MBA, has been Chief Executive Offer, Managing Director and Director of Dimerix Limited since August 27, 2018. Dr. Webster served as the Commercial Director of...

Leadership Team

NamePositionTenureCompensationOwnership
Nina Webster
CEO, MD & Director6.4yrsAU$759.06k0.073%
A$ 152.4k
David Fuller
Chief Medical Officer1.3yrsAU$361.30k0.0033%
A$ 6.8k
Robert Shepherd
Chief Commercialisation Officer1.2yrsAU$372.79kno data
Hamish George
CFO & Company Secretary6yrsno datano data
Kevin Pfleger
Chief Scientific Advisorno datano datano data

3.6yrs

Average Tenure

Experienced Management: DXB's management team is considered experienced (3.6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Nina Webster
CEO, MD & Director6.4yrsAU$759.06k0.073%
A$ 152.4k
Mark Diamond
Non-Executive Chairman1.1yrsAU$52.50kno data
Hugh Alsop
Independent Non-Executive Director7.7yrsAU$60.00kno data
Sonia Poli
Non Executive Director9.5yrsAU$60.00k0.10%
A$ 208.5k
Alessia Fornoni
Member of Medical Advisory Board7.3yrsno datano data
David Power
Member of Medical Advisory Board7.3yrsno datano data
Daniel Cattran
Member of Medical Advisory Board7.3yrsno datano data
Jonathan Hogan
Member of Medical Advisory Board7.3yrsno datano data
Clinton Snow
Non-Executive Director1.7yrsAU$60.00kno data
Laura Mariani
Member of ACTION3 Medical Advisory Boardless than a yearno datano data

7.3yrs

Average Tenure

Experienced Board: DXB's board of directors are considered experienced (7.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 15:50
End of Day Share Price 2025/01/02 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dimerix Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution